Terrorist attacks injure far more people than they kill, leaving victims with lost limbs, hearing loss, respiratory disease, depression and other issues. But little research has measured the impact of that damage beyond the number of people who are hurt. New research from The University of Texas at Dallas provides a more complete picture of […]Continue Reading ...
Among patients with cardiovascular disease, it’s a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular disease (CVD) appear to be intimately linked—they are frequently seen together although the underlying connection between the two […]Continue Reading ...
Dublin, Ireland – Thursday, June 21, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG), the leading global biotechnology company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for Cinryze (C1 esterase inhibitor [human]), making it available to help prevent angioedema attacks in children aged […]Continue Reading ...
Credit: University of Nottingham Serious asthma attacks in adults can be reduced by a temporary but significant increase in the dose of inhaled steroids during severe episodes of asthma, according to a new UK-wide study led by experts at the University of Nottingham. Previous research at the University has found that doubling the dose of […]Continue Reading ...
August 7, 2018 Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug-delivery system that allows rapid response to heart attacks without surgical intervention. In laboratory and animal testing, the system proved to be effective at dissolving clots, limiting long-term scarring to heart tissue and preserving […]Continue Reading ...
By Dr Ananya Mandal, MD,April 18, 2018 According to a pilot study results released yesterday (17th of April 2018), a new drug may help provide relief to people with migraine that is unsuccessfully treated with the currently available drugs. Researchers have developed Erenumab, which belongs to a human monoclonal antibody class of drugs that can […]Continue Reading ...
- Experts debate over whether gut or brain is more important in regulating appetite
- Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
- Low-Carb Diets May Work By Boosting Calorie Burn
- Key molecule responsible for learning and memory discovered
- New blood test developed for early diagnosis of ovarian cancer
- Researchers identify molecule to fight myotubular myopathy
- Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
- Scientists equip new virus that kills carcinoma cells with protein
- Novel approach could provide painless, efficient alternative for treating eye diseases
- Protein in cell membranes of sperm plays key role in finding their way to eggs
- Parents who decline flu vaccination for their child may be exposed to limited information
- Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
- FDA warns of common diabetes meds’ link to dangerous genital infection
- New methods for preserving shoulder function, quality of life in breast cancer patients
- Surprising discovery about BH4 may rekindle interest in once-promising pathway
- Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
- Beating breast cancer only to die of opioid use – a sad Appalachian story
- Workplace bullying or violence linked to higher risk of cardiovascular problems
- Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
- ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients